Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance

Cancer Cells Acquire Resistance to Anticancer Drugs: An Update

(2016) Hsing-Pang Lu et al.   Biomedical Journal

In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues

(2011) Caroline Haglund et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Mechanism of Cell Adaptation

(2011) Valentina Fodale et al.   CANCER JOURNAL

Identification of Agents that Induce Apoptosis of Multicellular Tumour Spheroids: Enrichment for Mitotic Inhibitors with Hydrophobic Properties

(2011) Walid Fayad et al.   Chemical Biology & Drug Design

Evolution from a Natural Flavones Nucleus to Obtain 2-(4-Propoxyphenyl)quinoline Derivatives As Potent Inhibitors of theS. aureusNorA Efflux Pump

(2011) Stefano Sabatini et al.   JOURNAL OF MEDICINAL CHEMISTRY

Mitosis is not a key target of microtubule agents in patient tumors

(2011) Edina Komlodi-Pasztor et al.   Nature Reviews Clinical Oncology

Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency

(2011) Wan Seok Yang et al.   ACS Medicinal Chemistry Letters

Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors

(2008) P. Ross-Macdonald et al.   MOLECULAR CANCER THERAPEUTICS

The fluorometric microculture cytotoxicity assay

(2008) Elin Lindhagen et al.   Nature Protocols

Potential Mechanisms of Resistance to Microtubule Inhibitors

(2008) Maria Kavallaris et al.   SEMINARS IN ONCOLOGY